Join the Hypereosinophilic Syndrome group to help and get support from people like you.
Hypereosinophilic Syndrome News
FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)
London UK 25 September 2020 – GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and pediatric patients...
Ask a question
To post your own question to this support group, sign in or create an account.